argenx SE (ARGX) Goldman Sachs forty seventh Annual International Healthcare Convention 2026 June 9, 2026 4:00 PM EDT
Firm Contributors
Arjen Lemmen – Vice President of Company Improvement & Technique
Karl Gubitz – Chief Monetary Officer
Convention Name Contributors
Rajan Sharma – Goldman Sachs Group, Inc., Analysis Division
Presentation
Rajan Sharma
Goldman Sachs Group, Inc., Analysis Division
Afternoon, everybody, and thanks for becoming a member of. My identify is Rajan Sharma, European pharma and biotech analyst right here at Goldman Sachs. Very happy to have argenx with us this afternoon for the final hearth of the day. And we have truly bought 2 audio system. We’re fortunate to have 2 audio system at present. We have Karl Gubitz, who’s CFO, who you all in all probability know. After which we even have Arjen Lemmen, who’s Head of Company Improvement. Possibly simply to kick off, Arjen, given that you simply’re in all probability somebody who hasn’t had as a lot time with buyers relative to Karl, perhaps you may simply give a short introduction of your position, your self, and the way that is developed through the years at argenx.
Arjen Lemmen
Vice President of Company Improvement & Technique
Sure. No, completely happy to take action and completely happy to be right here. So my position at argenx is certainly that I head Company Improvement and Technique. I have been with the corporate since 2015. So I joined argenx when it was simply 30 folks on the time with a duty on our Enterprise Improvement deal-making. I finally developed my position in a broader company improvement duty within the CDR management group.
So my group focuses on actually every part associated to 3rd events and deal-making. So the Enterprise Improvement, the partnerships, the alliances are sourcing with suppliers and Company Technique as a complete. So supporting the group, which nations can we enter, which indications can we prioritize does the general portfolio make sense? Which molecule can we
